Form 8-K - Current report:
SEC Accession No. 0001558370-24-009012
Filing Date
2024-06-07
Accepted
2024-06-07 16:30:17
Documents
16
Period of Report
2024-06-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K krbp-20240603x8k.htm   iXBRL 8-K 38268
2 EX-10.1 krbp-20240603xex10d1.htm EX-10.1 185199
3 GRAPHIC krbp-20240603xex10d1001.jpg GRAPHIC 899
  Complete submission text file 0001558370-24-009012.txt   404732

Data Files

Seq Description Document Type Size
4 EX-101.SCH krbp-20240603.xsd EX-101.SCH 3403
5 EX-101.LAB krbp-20240603_lab.xml EX-101.LAB 19388
6 EX-101.PRE krbp-20240603_pre.xml EX-101.PRE 13261
20 EXTRACTED XBRL INSTANCE DOCUMENT krbp-20240603x8k_htm.xml XML 4975
Mailing Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054
Business Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054 832-968-4888
Kiromic Biopharma, Inc. (Filer) CIK: 0001792581 (see all company filings)

EIN.: 464762913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39619 | Film No.: 241030020
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)